Canaccord Genuity Reiterates a 'Buy' on Edwards Lifesciences (EW); SAPIEN T-A Data Exceeds Expectations
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $89.79 -0.04%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Edwards Lifesciences (NYSE: EW) price target raised from $85 to $90.
Analyst, Jason R. Mills, said, "EW remains one of our two Best Ideas for 2012. Results from the non-randomized continued access (NRCA) program for PARTNER’s Cohort A trans-apical (T-A) delivery convincingly showed a significant reduction in 30-day stroke to 2.0% from 7.0% in Cohort A, exceeding our expectations. We think these data will quell FDA concerns and increase the likelihood FDA approves both T-F and T-A for high-risk patients (mid-‘12E)."
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $78.27 yesterday.
Analyst, Jason R. Mills, said, "EW remains one of our two Best Ideas for 2012. Results from the non-randomized continued access (NRCA) program for PARTNER’s Cohort A trans-apical (T-A) delivery convincingly showed a significant reduction in 30-day stroke to 2.0% from 7.0% in Cohort A, exceeding our expectations. We think these data will quell FDA concerns and increase the likelihood FDA approves both T-F and T-A for high-risk patients (mid-‘12E)."
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $78.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Mizuho Reiterates Outperform Rating on Broadcom Limited (AVGO) Into EPS
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
